Single-stranded DNA containing unmethylated cytosine-phosphate-guanine (CpG) motifs derived from microorganisms are recognized by Toll-like receptor (TLR) 9 and activate an innate immune response. TLR9 has two DNAbinding sites for CpG DNA and DNA containing cytosine at the second position from the 5 0 -end; both are required for efficient TLR9 activation in most vertebrate species. However, mouse TLR9 can be dimerized by CpG DNA only, although the underlying mechanism remains elusive. Here, we report the crystal structure of mouse TLR9 complexed with both DNAs. Although most TLR9-CpG DNA interactions are conserved among species, some are unique to mice and involved in species-specificity. These findings provide the structural basis for how mouse TLR9 dimerizes efficiently in response to CpG DNA to activate innate immunity.
The human body has numerous interacting immune defense mechanisms to fight microbial and viral pathogen infections. Constituents of invaded pathogens, including polysaccharides, fatty acids, proteins, and nucleic acids, are pathogen-associated molecular patterns (PAMPs) that stimulate the innate immune system, which has many types of pattern recognition receptors that recognize specific PAMPs as nonself, including Toll-like receptors (TLRs), nucleotide oligomerization domain-like receptors, and retinoic acid-inducible gene-I-like receptors [1] .
The TLR family is phylogenetically conserved from zebrafish to mammals [2, 3] . Ten TLRs (TLR1-TLR10) that recognize different PAMPs have been identified in humans [4] . TLRs share an N-terminal extracellular leucine-rich repeat (LRR) domain, single membranespanning domain, and a C-terminal cytoplasmic toll/IL-1R homology (TIR) domain. The LRR domain recognizes PAMPs and engages a unique set of adaptor proteins through the TIR domain to activate downstream nuclear factor (NF)-jB signaling and stimulate type I interferon (IFN) production. TLR3, TLR7, TLR8, and TLR9 are localized in endosomes and detect nucleic acids [1], including double-stranded RNA for TLR3 [5] , single-stranded (ss)RNA for TLR7 [6] and TLR8 [7] , and single-stranded DNA containing an unmethylated cytosine-phosphate-guanine (CpG) dinucleotide motif for TLR9 [8] .
TLR9 is expressed in B cells, plasmacytoid dendritic cells, and monocyte-macrophage-lineage cells [9] . The unmethylated CpG motif recognized by TLR9 is present at a lower frequency in the mammalian genome than in microbial DNA [10] . Since DNA is a ubiquitous molecule in all organisms, TLR9 activation is stringently regulated by multiple mechanisms to avoid inappropriate immune responses to self-derived DNA [11] . On the other hand, synthetic TLR9 agonists can be used as an adjuvant in tumor immunotherapy that function by stimulating the TLR9 signaling [12] . TLR9 antagonists may also be used to suppress the TLR9 pathway in autoimmune diseases [13, 14] .
TLR7, TLR8, and TLR9 constitute a TLR subfamily and share functional and structural features; the extracellular region comprises 26 LRRs and contains a long loop region known as the Z-loop between LRR14 and LRR15, whose cleavage is required for activation [11, [15] [16] [17] [18] [19] [20] (Fig. S1 ). Recent structural studies have shown that TLR9 harbors two ligand-binding sites for CpG DNA and DNA containing cytosine at the second position from the 5 0 -end (5 0 -xCx DNA) that act synergistically for efficient receptor dimerization. The dimerization of TLR9 is enhanced by 5 0 -xCx DNA in the presence of CpG DNA [21, 22] . TLR7 and TLR8 also simultaneously bind to two types of ligandssRNA and mononucleoside (guanosine for TLR7 and uridine for TLR8)-for dimerization [23, 24] .
Interestingly, human TLR9 requires both CpG and 5 0 -xCx motifs for activation, whereas mouse (Mus musculus; Mm) TLR9 can be effectively activated by CpG DNA only [25] [26] [27] . In fact, the proportion of TLR9 present as a dimer in horse (Equus caballus; Ec) and cow (Bos taurus; Bt) upon induction by CpG DNA alone is much lower than that of MmTLR9, as determined by SEC [21, 22] . These observations suggest that the mode of interaction between MmTLR9 and CpG DNA is distinct from that of TLR9 in other species. However, the mechanism by which CpG DNA is recognized by MmTLR9 has not yet been elucidated due to a lack of structural information. Here, we report the structure of the activated dimer form of MmTLR9 in complex with CpG and 5 0 -xCx DNAs. The structure reveals species-specific interactions between MmTLR9 and CpG DNA and residues at the dimerization interface of MmTLR9 that is distinct from those in other species. Structure-based mutagenesis confirmed the importance of these residues for the species-specific activation mechanism of MmTLR9.
Experimental procedures
Protein expression, purification, and crystallization
The recombinant extracellular domain of TLR9 proteins from mouse (M. musculus; MmTLR9; residues 26-818), horse (E. caballus; EcTLR9; residues 26-817), and bovine (B. Taurus; BtTLR9, residues 25-815) were expressed in Drosophila S2 cells and purified as described previously [22] . For crystallization, a mutant MmTLR9 with four N-glycosylation site mutations (N325Q, N495Q, N514Q and N670Q) was used. Crystallization experiments were performed with a sitting-drop vapor-diffusion method at 293 K. The crystallization droplets were made by mixing an equivalent volume (0.2 lL) of protein solution (6 X-ray diffraction data collection and structure determination X-ray diffraction datasets were collected on beamline SPring-8 BL41XU (Hyogo, Japan) under cryogenic condition at 100 K. Crystals were soaked in a cryoprotectant solution (20% (w/v) PEG 4000, 0.15 M ammonium sulfate, 0.1 M HEPES-NaOH pH 7.0, 0.35 M NaCl, 20% (v/v) ethyleneglycol) and then flash-cooled under cold gas stream. The diffraction datasets were processed using the XDS [28] program. The initial phases for the MmTLR9 structures were determined by the molecular replacement method using the Molrep [29] program using the MmTLR9 unliganded-form Highest resolution shell is shown in parenthesis.
structure (PDB ID: 3WPF). The model was further refined with stepwise cycles of manual model building using the COOT program [30] and restrained refinement using REFMAC [31] . 
Gel filtration chromatography analysis
Gel-filtration chromatography was performed using a Superdex 200 Increase 10/300 GL column (GE Healthcare UK Ltd., Buckinghamshire, UK) in a running buffer (10 mM MES-NaOH pH 5.5 and 150 mM NaCl) at a flow rate of 1 mLÁmin À1 . For Fig. 1 , the sample containing 1 lM TLR9, with or without 2 lM of the corresponding DNA (total volume, 200 lL), was injected and the eluate was monitored for absorbances at 280 nm and 260 nm. For Fig. 6 , the sample containing 2 lM TLR9, with or without 4 lM of the corresponding DNA was injected.
Small-angle X-ray scattering
Size-exclusion chromatography coupled with small-angle X-ray scattering (SEC-SAXS) experiment was performed on beamline PF BL10C (Ibaraki, Japan). The sample containing 56 lM TLR9, with or without the 84 lM of the corresponding DNA (total volume, 200 lL) was injected onto a Superdex 200 Increase 10/300 GL column (GE Healthcare UK Ltd.) in a running buffer (10 mM MESNaOH pH 5.5 and 150 mM NaCl). During SAXS data collection, the flow rate of SEC was set to 0.025 mLÁmin À1 .
Successive SAXS data (each 20 s exposure) were collected directly from SEC eluate at 293 K using PILATUS 2M (DECTRIS Ltd., Baden-Daettwil, Switzerland) with the sample-to-detector distance of 2.0 m. The wavelength of the X-rays was set to 1 0000 A. One-dimensional scattering data I(q) as a function of q (q = 4p sinh/k, where 2h is the scattering angle and k is the wavelength) were obtained through the circular averaging of each SAXS data, background subtraction, and data averaging by using the SAngler program [32] .
NF-jB-dependent luciferase reporter assay
Nuclear factor-jB-dependent luciferase reporter assay to check mouse TLR9 response was carried out as previously described [22] . In brief, HEK293T cells were transiently transfected with wild-type mouse TLR9 cDNA in pMXpuro-IRES-ratCD2, wild-type mouse Unc93B1 cDNA in pMX-puro and pELAM1-luc reporter plasmid, using PEI (Polyethylenimine 'Max', MW 40 000; Polysciences, Inc., Warrington, PA, USA). At 30 h after transfection, cells in a collagen-coated flat 96-well plate (Corning Inc., Corning, NY, USA) were stimulated with various DNA ligands for 6 h. Stimulated cells were lysed by Cell Culture Lysis Reagent (Promega Corporation, Madison, WI, USA) and subjected to a luciferase assay using the Luciferase Assay System (Promega Corporation). The relative light unit of chemiluminescence was measured by GloMax 96 Microplate Luminometer (Promega Corporation).
Oligonucleotides
The oligonucleotides used for SEC and crystallographic analyses were single stranded DNAs with normal phosphodiester linkages. Oligonucleotides for the luciferase reporter assay were single stranded DNAs with phosphorothioate linkages. All phosphodiester DNAs were purchased from Eurofins Genomics (Ebersberg, Germany). Phosphorothioate DNAs were purchased from FASMAC (Kanagawa, Japan).
Results

MmTLR9 dimerization is induced by CpG DNA alone
To analyze the sequence requirement and dimerization efficiency of MmTLR9, we performed SEC analysis using various 10-mer CpG DNAs with different 5 0 -flanking sequences. In MmTLR9, all CpG DNAs tested induced an upward shift of the MmTLR9 peak, indicating that MmTLR9 was dimerized (Fig. 1A) . AAACGTTTTT and GGGCGTTTTT induced dimerization of MmTLR9 more efficiently than TTTCGTTTTT and CCCCGTTTTT, which corresponds to the optimal CpG DNA sequence for TLR9 activation of RRCGYY (where R and Y represent a purine and pyrimidine respectively) [10] . Consistent with our recent report [21] , MmTLR9 dimerization was further enhanced by 5 0 -xCx DNA. On the other hand, when only CpG DNA was added, EcTLR9 mostly eluted at a position corresponding to the monomer and only a small dimer peak was observed (Fig. 1B) although CpG DNA was bound to EcTLR9, as determined by the increase in the ratio of absorbances at 260 and 280 nm. In the presence of both CpG and 5 0 -xCx DNA, EcTLR9 was almost completely dimerized. These results highlight the differences in CpG DNA-induced dimerization between murine and equine TLR9, with the former showing greater dimerization efficiency after binding to CpG DNA.
Structural features of MmTLR9 dimer induced by CpG DNA
To investigate the structural basis of efficient MmTLR9 dimerization induced by CpG DNA, we determined the crystal structure of MmTLR9 complexed with a 10-mer CpG DNA (AGGCGTTTTT) and 6-mer 5 0 -xCx DNA (TCGCCA). MmTLR9/CpG DNA/5 0 -xCx DNA represents a 2 : 2 : 2 complex similar to recently reported EcTLR9/CpG DNA/5 0 -xCx DNA structures (with typical sequences AGGCGTTTTT for CpG DNA and TCGCAC for 5 0 -xCx DNA; PDB ID: 5Y3J) [21] (Fig. 2B-D) . CpG DNA and 5 0 -xCx DNA are bound to their respective binding sites in an identical manner with the same conformations in MmTLR9 and EcTLR9 dimers. CpG DNA mainly interacts with one protomer of the MmTLR9 dimer through its CpG dinucleotide accommodated in the N-terminal groove of MmTLR9-which is formed between the lateral surface of LRR N-terminal domain, LRR1, and the protruding loop region of LRR2-while simultaneously interacting with the other protomer of MmTLR9* at the C-terminal LRR21* and LRR22* (with the asterisks indicating the second protomers in the dimer throughout this paper). The first three nucleotides (TCG) on the 5 0 side of 5 0 -xCx DNA are sandwiched by two protomers between LRR8-i.e., LRR11-LRR13 and LRR17*-LRR19*-and are specifically recognized, whereas the rest of the DNA protrudes and lacks visible electron density (Fig. 2C) .
Although most of the residues of MmTLR9 directly involved in the interaction with CpG DNA are conserved in EcTLR9 [21, 22] (Figs 2D and S1 ), there are four that differed between the two orthologs (MmTLR9: Leu106, Ser109, Ile643*, and Ser667*; EcTLR9: Met106, Pro109, Thr642*, and Ala666*). The bulky and hydrophobic side chain of Ile643* in LRR21* of MmTLR9 has a larger contact area with the backbone moieties of CpG dinucleotide and also contributes to the hydrophobic interactions between LRR2 and LRR21* and LRR22* through Pro105 and Phe668* along with mouse-specific Leu106, which promotes dimerization (Fig. 3) . Furthermore, the side chain -OH group of Ser667* in MmTLR9 forms a direct hydrogen bond with the backbone phosphate of the CpG motif, which is not observed in EcTLR9. The main chain but not the side chain atoms of Ser109 are in contact with DNA, suggesting that this Ser does not contribute to the species specificity. In addition to CpG DNA-mediated interactions, protein-protein interactions between two protomers may contribute to the species specificity. The main chain conformations of the dimerization interfaces are essentially identical between MmTLR9 and EcTLR9 (Fig. 4A) . Species-specific hydrogen bonds are observed near the CpG DNA binding site in the MmTLR9 structure-i.e., between Pro105 and Arg645* (Leu644* in EcTLR9), His107 and Gln647* (Cys646 in EcTLR9), and Gly792 and Lys739* (Arg738* in EcTLR9)-whereas hydrogen bonds between Arg262, Gln612*, and Glu616* (Pro262, Arg613*, and Glu617* in MmTLR9), His505 and Gln558*, and Ala736 and Gln797* (Ile737 and Gln798* in MmTLR9) are only present in EcTLR9 (Fig. 4B,C) .
Collectively, these species-specific CpG DNAmediated and protein-protein interactions in MmTLR9 may strengthen the dimerization between two protomers in MmTLR9.
MmTLR9 dimer induced by CpG DNA alone or in conjunction with 5 0 -xCx DNAs exhibit similar structures in solution Since we were unable to obtain crystals of MmTLR9 dimer induced by CpG DNA alone, we carried out SEC coupled with small-angle X-ray scattering (SEC-SAXS) analysis to obtain structural information on this molecule. The scattering curves for the MmTLR9/CpG DNA and MmTLR9/CpG DNA/5 0 -xCx DNA complexes eluted in the same volume in the SEC analysis shows good concordance, suggesting that the two structures are similar (Fig. 5A) . On the other hand, the two curves for EcTLR9/CpG DNA and EcTLR9/CpG DNA/ 5 0 -xCx DNA shows different patterns for the major peak (Fig. 1) , reflecting their different elution volumes in the SEC analysis (Fig. 5B) . These results suggest that the overall structure of the MmTLR9 dimer induced by CpG DNA alone is similar to that induced by both CpG-and 5 0 -xCx DNAs. Thus, interactions observed for MmTLR9/ CpG DNA/5 0 -xCx DNA are likely conserved in MmTLR9/CpG DNA.
Mouse-specific Leu106 and Ile643 are important for CpG DNA-induced dimerization and activation of MmTLR9
To examine whether Ile643 and Ser667 are important for the species specificity of the MmTLR9-CpG DNA interaction, we generated MmTLR9 harboring mutations in the residues of the human counterpart and evaluated in vitro dimerization of these mutants by SEC (Fig. 6A) . The I643T and I643T/S667A mutations reduced MmTLR9 dimerization induced by CpG DNA, whereas the S667A mutation alone had little effect. We also examined the activity of these TLR9 mutants with the luciferase reporter assay in HEK293T cells (Fig. 6B) . Consistent with the above results, the I643T and I643T/S667A mutations reduced cellular activation compared to wild--type MmTLR9, whereas the S667A mutation had a weaker effect. Notably, the L106M mutation also decreased cellular activity to a degree comparable to the I643T mutation. Leu106 engages in hydrophobic interaction with Ile643 in MmTLR9; thus, mutating this residue weakened the activity (Fig. 3) . S109P did not affect activation, as the side chain atoms of this residue had not engaged in any interaction. These results suggest that Leu106 and Ile643 are important for CpG DNA-induced dimerization and activation of MmTLR9. 
Discussion
TLR9 activates the immune response by recognizing unmethylated CpG DNAs that are present at a high frequency in microbial as compared to vertebrate DNA [33] . Human TLR9 requires a pair of CpG motifs for activation, whereas in mouse, a single motif suffices [25] [26] [27] . However, since there is no structural information available for a form of MmTLR9 activated by CpG DNA binding, the species specificity of TLR9 activation by CpG DNA remains unclear. It was recently demonstrated that short 5 0 -xCx DNA potentiates TLR9 activation in the presence of CpG DNA [34] . Moreover, the crystal structures of the ternary complex of equine or bovine TLR9 with both CpG and 5 0 -xCx DNAs have revealed that 5 0 -xCx DNA binds to a site distinct from the CpG DNAbinding site and induced TLR9 dimerization and activation by interacting with two TLR9 protomers [21] . In this study, we determined the crystal structure of an activated form of MmTLR9 complexed with CpG DNA and 5 0 -xCx DNA, which reveals that the modes of recognition of CpG DNA and 5 0 -xCx DNA are highly conserved among horse, cow, and mouse TLR9 but also shows some differences that might be relevant to the species specificity of TLR9 activation. In fact, mutation of mouse-specific Ile643 impaired CpG DNA-induced dimerization of MmTLR9 (Figs 1 and  5A) . Additionally, the reporter assay revealed that mouse-specific Leu106 and Ile643 are important for MmTLR9 activation. Interestingly, these two residues are restricted to the Murinae subfamily (Fig. S1) . In addition to the difference in CpG DNA-mediated interactions, TLR9 dimerization in different species is achieved through different residues at the protein-protein interface (Figs 4C and S1 ). Despite their overall structural similarity, these local differences in structure may explain why MmTLR9 is more easily dimerized by CpG DNA than TLR9 in other species.
MmTLR9 is expressed in macrophages and bone marrow-derived dendritic cells [8] , which are broadly distributed in tissues throughout the body. In contrast, human TLR9 expression is restricted to plasmacytoid dendritic cells (pDCs) [33] and B cells [9] , which are found only in lymphoid tissues. pDCs are a specialized cell type that produce large amounts of type I IFN (IFN-a and -b) in the antiviral immune response. Human TLR9 requires both CpG and 5 0 -xCx DNAs for full activation; TLR7 [23] and TLR8 [24] also require two ligands, mononucleoside and ssRNA. This dual recognition of two ligands may guarantee efficient TLR activation. In contrast to the stringently regulated activation of human TLR9, MmTLR9-despite being synergistically activated by two DNAs-can be activated by CpG DNA alone in the response to invasive pathogens. Each scenario may have an evolutionary advantage for host defense.
In summary, the crystal structure of an activated form of MmTLR9 along with previously determined structures revealed similarities and differences in the dimerization mechanism among TLR9 from different species. Our results provide novel insights into ligand recognition and activation mechanisms of TLR9.
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